RESUMEN
CONTEXT: In fibrous dysplasia (BFD), normal bone and bone marrow are replaced by fibro-osseous tissue, leading to fracture, deformity and pain. BFD may be isolated, or in association with cutaneous hyperpigmentation and/or hyperfunctioning endocrinopathies, termed McCune-Albright syndrome (MAS). GH hypersecretion has been described in 10%-20% of MAS-BFD patients. Aim of the study was to determine the impact of GH-insulin like growth factor 1 (IGF1) axis hyperactivity on MAS-BFD morbidities and the efficacy of GH excess therapy. DESIGN AND PATIENTS: A multicentric cross-sectional analysis was conducted on three different MAS cohorts. From 195 MAS patients, 37 subjects (19%) with GH excess were identified and compared with 34 MAS controls without GH hypersecretion. RESULTS: Mean head circumference SDS was significantly higher in GH excess: 4.025 SDS vs 0.683 SDS (P < .0001). The risk of optic neuropathy (Odds ratio 4.231; P = .039), hearing deficit (Odds ratio 2.961; P = .0481), facial asymmetry (Odds ratio 6.563; P = .0192), malignancies (Odds ratio 15.24; P = .0173) were higher in GH excess group. Overall, pharmacotherapy (octreotide alone 10-30 mg/mo or with pegvisomant 10-20 mg/d) was effective in IGF1 normalization (IGF1 Z-score between -2 and +2 SDS) in 21/29 patients (72.4%) with good compliance to the regimen. Late diagnosis and GH excess treatment after 16 years old of age was associated with an increased risk of optic neuropathy (Odds ratio 4.500; P = .0491) and growth of pituitary adenomas (Odds ratio 7.846; P = .050). CONCLUSIONS: GH-IGF1 hyperactivity increases risk of morbidities in MAS. Medical therapy is effective in normalizing IGF1 in most patients, and early treatment during paediatric age is associated with a decreased risk of optic neuropathy and GH-secreting adenomas growth.
Asunto(s)
Displasia Fibrosa Poliostótica/metabolismo , Hormona del Crecimiento/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Adolescente , Adulto , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Estudios Multicéntricos como Asunto , Adulto JovenRESUMEN
BACKGROUND: In polyostotic fibrous dysplasia (PFD) affecting the femur, 6 types of stable femoral deformities have been identified, ranging from the mild type 1 to the most severe type 6. The purpose of our study was to identify the type of deformity present at diagnosis in children with PFD affecting the femur, and to investigate possible changes in the original type with growth. METHODS: Twenty-seven children affected by either PFD or McCune-Albright syndrome, with 46 affected femurs, were consecutively observed from 1994 to 2010. Radiographs of the pelvis and femurs were taken at diagnosis, and afterward at regular intervals of 6 to 12 months depending on the clinical evolution of each case. Radiographs of the femurs taken at 3 and 7 years after diagnosis were selected to assess the evolution of the femoral deformity. Deformities were classified according to the femoral shape, neck-shaft angle value, and the presence of shepherd's crook deformity evaluated on AP radiographs. RESULTS: The average age of the patients at diagnosis was 5 years (range, 2 to 11 y). At diagnosis, 30 femurs were type 1; 12, type 2; 1, type 3; 1, type 4; and 2, type 5. Three years later, 39% of the femurs had maintained the original deformity present at diagnosis, whereas only 13% did so 7 years after diagnosis.Predictors of change to a more severe type were: younger age at diagnosis, McCune-Albright syndrome, rapid spreading of fibrodysplastic tissue from the trochanteric area to the proximal femoral shaft, cortical thinning of the proximal femur, calcar osteolysis, and presence of an intertrochanteric cystic-like lesion eroding the calcar. CONCLUSIONS: In children with PFD affecting the femur, 61% of the femoral deformity present at diagnosis switched to a more severe type of deformity within 3 years from diagnosis, whereas 87% either shifted to a more severe type of deformity or already had corrective surgery within 7 years after diagnosis. LEVEL OF EVIDENCE: Level IV.
Asunto(s)
Fémur/diagnóstico por imagen , Displasia Fibrosa Poliostótica/diagnóstico por imagen , Adolescente , Niño , Preescolar , Progresión de la Enfermedad , Femenino , Humanos , Masculino , RadiografíaRESUMEN
McCune-Albright Syndrome (MAS) is a congenital endocrine disorder due to mosaic tissutal hyper-function. We describe a boy with a molecularly confirmed MAS, clinically evident with congenital café-au-lait spots, bone fibrous dysplasia, hyperthyroidism, and renal phosphate wasting syndrome. At 4.6 years of age he disclosed a rapid progression of peripheral puberty, so we decided to treat him with bicalutamide 25 mg/day and anastrozole 1 mg/day. Combined third generation aromatase inhibitors - competitive androgen receptor blockers were employed in familial male precocious puberty (FMPP). Combined treatment was performed for 49 months from the age of 4.6 to 6.7 years. The patient underwent clinical, laboratory, and instrumental evaluation twice a year from the first admission to the current age. This treatment caused a rapid normalization of growth velocity, subsequent reduction of penile androgenization, and stabilization of testicular volume. The therapy was well tolerated for all its duration and neither side effects, nor secondary hypothalamic activation were noted. This report provides further evidence of effectiveness and safety of combined third generation aromatase inhibitors - competitive androgen receptor blockers in male precocious peripheral puberty, firstly employed in male MAS, and contributes to expand the spectrum of disorders in which their employment may reveal promising.
Asunto(s)
Antagonistas de Andrógenos/uso terapéutico , Anilidas/uso terapéutico , Inhibidores de la Aromatasa/uso terapéutico , Displasia Fibrosa Poliostótica/fisiopatología , Nitrilos/uso terapéutico , Pubertad Precoz/tratamiento farmacológico , Pubertad Precoz/etiología , Compuestos de Tosilo/uso terapéutico , Triazoles/uso terapéutico , Anastrozol , Antagonistas de Andrógenos/efectos adversos , Anilidas/efectos adversos , Inhibidores de la Aromatasa/efectos adversos , Desarrollo Infantil/efectos de los fármacos , Preescolar , Quimioterapia Combinada/efectos adversos , Humanos , Masculino , Nitrilos/efectos adversos , Compuestos de Tosilo/efectos adversos , Resultado del Tratamiento , Triazoles/efectos adversosRESUMEN
BACKGROUND: The leydigioma is the most frequent interstitial neoplasm of the testis. Clinical symptoms of all leydigioma usually are isosexual precocious pseudo-puberty due to autonomous testosterone overproduction, suppressed gonadotropin levels and a testis mass. Nowadays its therapy is debated. DESIGN AND METHODS: We report a case of a young child treated in 2008 for a leydigioma of the testis with atypical clinical behavior. Testicular oncologic markers and hormonal profile were assessed. RESULTS: The patient was treated successfully with organ-confined surgery. CONCLUSION: We want to confirm the safety of conservative surgery against radical orchiectomy and review the literature of the last decade on this debated matter.
Asunto(s)
Tumor de Células de Leydig/cirugía , Tratamientos Conservadores del Órgano/métodos , Neoplasias Testiculares/cirugía , Testículo/cirugía , Preescolar , Humanos , MasculinoRESUMEN
Congenital adrenal hyperplasia (CAH) is an autosomal recessive enzymatic defect caused by mutations or deletions of the cytochrome P450 21-hydroxylase CYP21 gene. Oral therapy with glucocorticoids and mineralcorticoids is administered to prevent adrenal crisis and to control hyperandrogenism. During puberty this type of therapy is difficult to manage owing to physiological and hormonal changes and poor compliance. We describe a case of a pubertal boy affected by CAH, in whom continuous subcutaneous infusion of hydrocortisone led to improved metabolic control and compliance.
Asunto(s)
Hiperplasia Suprarrenal Congénita/tratamiento farmacológico , Antiinflamatorios/administración & dosificación , Hidrocortisona/administración & dosificación , Adolescente , Conducta del Adolescente/psicología , Hiperplasia Suprarrenal Congénita/fisiopatología , Hiperplasia Suprarrenal Congénita/psicología , Antiinflamatorios/uso terapéutico , Sistemas de Liberación de Medicamentos , Glucosuria/etiología , Glucosuria/prevención & control , Humanos , Hidrocortisona/uso terapéutico , Infusiones Subcutáneas , Masculino , Cumplimiento de la Medicación/psicología , Pubertad Precoz/etiología , Resultado del TratamientoRESUMEN
Ectopic adrenocorticotrophic hormone (ACTH) secretion is a rare cause of Cushing syndrome in paediatric age, due to tumours arising from different tissues. To date, only 11 reports of ACTH-secreting pancreatic tumours in children and adolescents exist in the literature. We present a paediatric case of Cushing syndrome caused by ectopic ACTH secretion. This was caused by a large acinar cell carcinoma that developed in the pancreas of a 3-year-old girl.
Asunto(s)
Hormona Adrenocorticotrópica/metabolismo , Carcinoma de Células Acinares/complicaciones , Síndrome de Cushing/etiología , Síndrome de Cushing/metabolismo , Neoplasias Pancreáticas/complicaciones , Carcinoma de Células Acinares/metabolismo , Carcinoma de Células Acinares/patología , Preescolar , Terapia Combinada , Síndrome de Cushing/patología , Procedimientos Quirúrgicos del Sistema Digestivo , Femenino , Humanos , Cetoconazol/uso terapéutico , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/patología , Resultado del TratamientoRESUMEN
Human GATA3 haploinsufficiency leads to HDR (hypoparathyroidism, deafness, and renal dysplasia) syndrome. The development of a specific subset of organs in which this transcription factor is expressed appears exquisitely sensitive to gene dosage. We report on a 14-year-old patient with symptomatic hypoparathyroidism, sensorineural bilateral deafness, unilateral renal dysplasia, bilateral palpebral ptosis, and horizontal nystagmus. Fundoscopy displayed symmetrical pseudopapilledema, and brain CT scan revealed basal ganglia calcifications. FISH analysis did not disclose any microdeletion in the 22q11.2 or 10p14 regions. GATA3 mutation analysis identified a heterozygous deletion of GG nucleotides at codon 36 and 37 (c.108_109delGG) in exon 2 causing a frameshift with a premature stop codon after a new 15-aminoacid sequence. Restriction endonuclease analysis performed in parents was negative. Our patient carries a novel "de novo" GATA3 mutation, providing further evidence that HDR syndrome is caused by haploinsufficiency of GATA3, which may be responsible for a complex neurologic picture besides the known triad.
Asunto(s)
Factor de Transcripción GATA3/genética , Pérdida Auditiva Sensorineural/genética , Hipoparatiroidismo/genética , Riñón/anomalías , Mutación , Adolescente , Secuencia de Aminoácidos , Secuencia de Bases , Blefaroptosis/genética , Codón sin Sentido , ADN/genética , Análisis Mutacional de ADN , Mutación del Sistema de Lectura , Humanos , Masculino , Datos de Secuencia Molecular , Nistagmo Patológico/genética , Eliminación de Secuencia , SíndromeRESUMEN
Bone alterations in phenylketonuria (PKU) have been detected, especially with increasing age, in several studies by using different radiologic techniques. Quantitative ultrasound (QUS) assesses skeletal status by measuring the amplitude-dependent speed of sound (AD-SoS) and the bone transmission time (BTT), mainly dependent on mineral density and cortical thickness. Bone condition in 30 children and adolescents (mean age 15.1 +/- 6.4 y) affected by PKU was evaluated by phalangeal QUS, considering its relationship with their clinical, biochemical and therapeutic features. Measured AD-SoS Z-Score and BTT Z-Score were 0.27 +/- 1.42 and -0.26 +/- 1.21, respectively. In patients with previous fractures, the two QUS parameters were lower than in patients without history of fracture (p < 0.001 and p = 0.006, respectively). AD-SoS Z-Score and BTT Z-Score were negatively correlated with plasma phenylalanine (Phe) concentration in the year before QUS (p = 0.005 and p < 0.001, respectively) and with age (p < 0.001 for both parameters). These results parallel the previous findings obtained by different radiologic tools and suggest phalangeal QUS as an attractive option for the regular evaluation and longitudinal monitoring of bone condition in children and adolescents affected by PKU.
Asunto(s)
Falanges de los Dedos de la Mano/diagnóstico por imagen , Fenilcetonurias/diagnóstico por imagen , Adulto , Envejecimiento/fisiología , Índice de Masa Corporal , Estudios Transversales , Femenino , Falanges de los Dedos de la Mano/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Fenilalanina/sangre , Fenilcetonurias/sangre , Fenilcetonurias/fisiopatología , Proyectos Piloto , UltrasonografíaRESUMEN
This article aims to analyse a possible manner of approaching the birth of intersexual children. We start out by summing up what intersexuality is and how it is faced in the dominant clinical practice (the "treatment paradigm"). We then argue against this paradigm, in favour of a postponement of genital surgery. In the second part of this paper, we take into consideration the general question of whether only two existing sexes are to be recognized, arguing in favour of an expansion of sex categories. In the third part, we illustrate the reasons supporting provisional sex attribution: the child's best interest and respect for their developing moral autonomy. This position aims to increase the child's well-being and self-determination, limiting parents' freedom to take decisions on behalf of others, in particular, those decisions concerning basic aspects of their children's personal identity.
Asunto(s)
Defensa del Niño/ética , Toma de Decisiones/ética , Trastornos del Desarrollo Sexual/cirugía , Genitales/cirugía , Consentimiento Paterno/ética , Procedimientos Quirúrgicos Urogenitales/ética , Discusiones Bioéticas , Protección a la Infancia , Preescolar , Trastornos del Desarrollo Sexual/psicología , Femenino , Genitales/anomalías , Humanos , Lactante , Recién Nacido , Masculino , Padres , Autonomía Personal , EmbarazoRESUMEN
The case of an 8-year-old boy with severe bone mass reduction and 4 fractures as a result of an unsupervised diet established to treat cow's milk allergy is presented. Endocrine, genetic and orthopedic pathologies were excluded. While vitamin D intake had always been appropriate, his calcium intake had been inadequate for many years. This clinical report suggests that both vitamin D and calcium supplementation are necessary when a cow's milk protein-free diet is prescribed, even when a hypo- or non-allergenic formula is provided.
Asunto(s)
Calcio de la Dieta/administración & dosificación , Calcio/deficiencia , Calcio/uso terapéutico , Fracturas Óseas/etiología , Hipersensibilidad a la Leche/complicaciones , Calcio/metabolismo , Niño , Suplementos Dietéticos , Humanos , Masculino , Vitamina D/administración & dosificaciónRESUMEN
In this review we report the literature about ovarian function of young women with McCune-Albright Syndrome and describe our personal experience in the follow-up of a small cohort.Collectively, the existing data demonstrate that ovarian hyperfunction with ovarian cysts and hyperestrogenism persists in those women who had precocious puberty. The recording of menstrual cycles and the analysis of gonadotropin and estrogen secretion indicate that, when hypothalamic-pituitary pubertal activation begins, alternating episodes of gonadotropin control and ovarian autonomy can be seen. The persistence of estrogen hypersecretion causes menstrual disturbances and hypofertility. The long term consequences of this condition are hypothesized to be an increased risk of ductal breast cancer, which seems to be higher when growth hormone hypersecretion is also present. Therefore, young MAS women should receive counseling regarding fertility and ongoing surveillance for the development of estrogen related diseases.
Asunto(s)
Estrógenos/sangre , Displasia Fibrosa Poliostótica/sangre , Displasia Fibrosa Poliostótica/complicaciones , Pubertad Precoz/sangre , Pubertad Precoz/etiología , Niño , Femenino , Displasia Fibrosa Poliostótica/patología , Humanos , Ovario/patología , Pubertad Precoz/patologíaRESUMEN
McCune-Albright syndrome consists of polyostotic fibrous dysplasia, precocious puberty and cafè-au-lait skin lesions. Bone lesions are characterized by the presence of fibrous connective tissue with a characteristic whorled pattern and containing trabeculae of immature non-lamellar (woven) bone. They may be solitary (monostotic) or multiple (polyostotic). Commonly involved bones include the femur, tibia, ribs and facial skeleton. In the fibula pseudo-cystic areas and 'ground glass'-like areas, in the femur 'shepherd crook' deformation due to weight on a less resistant bone and secondary to many cortical microfractures, are typical. MRI gives the exact delimitation of the lesions and is especially indicated in the followup of monostotic forms and in the outcome of surgical corrections. Bone scintigraphy with technetium 99 is essential in the follow-up of the disease. Ultrasonography is very useful in ovarian cyst follow-up and in the detection of thyroid and adrenal nodules and testicular microlithiasis.
Asunto(s)
Huesos/patología , Manchas Café con Leche/diagnóstico , Displasia Fibrosa Poliostótica/diagnóstico , Pubertad Precoz/diagnóstico , Manchas Café con Leche/complicaciones , Manchas Café con Leche/diagnóstico por imagen , Diagnóstico por Imagen/métodos , Enfermedades del Sistema Endocrino/complicaciones , Enfermedades del Sistema Endocrino/diagnóstico , Enfermedades del Sistema Endocrino/diagnóstico por imagen , Femenino , Displasia Fibrosa Poliostótica/complicaciones , Displasia Fibrosa Poliostótica/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Masculino , Pubertad Precoz/complicaciones , Pubertad Precoz/diagnóstico por imagen , Cintigrafía , Testículo/patología , UltrasonografíaRESUMEN
Ovarian cysts are common in peripheral precocious puberty in McCune-Albright syndrome (MAS). The clinical course of these cysts is unpredictable due to episodes of hyperestrogenism typical of MAS ovarian hyperfunction. In persistent and recurrent large ovarian cysts with sustained estrogen hypersecretion and relevant clinical disturbances (increased linear growth and bone age maturation, vaginal bleeding and psychological disturbances) treatment is mandatory. Experimental courses of estrogen-blocking drugs may have insufficient or nil therapeutic effects. In these cases and when molecular analysis is required to obtain MAS diagnosis as in isolated peripheral precocious puberty, surgery is the option. Laparoscopy minimizes surgical aggression and facilitates obtaining tissue samples for molecular analysis, and sometimes relieves hyperestrogenism with the excision of hyperactive ovarian areas. It can be conducted with trans-umbilical laparoscopic ovarian cystectomy (TULOC) before 3 years of age and with traditional techniques afterwards.
Asunto(s)
Displasia Fibrosa Poliostótica/complicaciones , Laparoscopía/métodos , Quistes Ováricos/cirugía , Pubertad Precoz/cirugía , Niño , Preescolar , Cromograninas , Femenino , Displasia Fibrosa Poliostótica/genética , Displasia Fibrosa Poliostótica/cirugía , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Humanos , Lactante , Mosaicismo , Mutación , Quistes Ováricos/etiología , Quistes Ováricos/genética , Pubertad Precoz/complicaciones , Pubertad Precoz/genéticaRESUMEN
McCune-Albright syndrome (MAS) is a rare proteiform disease due to postzygotic, somatic mutations at codon R201 of the GNAS1 gene that results in cellular mosaicism. Different methods have been used in the molecular analysis of DNA samples from several tissues of patients with one or more MAS signs, with various mutation detection rates. We review data from the literature to investigate whether patient inclusion criteria for GNAS1 analysis, the molecular methods used to search for R201 mutations, and the type of tissues analysed, can influence the mutation detection rate in MAS. Our study indicates that to overcome the problems related to GNAS1 analysis in MAS, sensitive and specific molecular methods must be used to look for the mutation from all available affected tissues and from easily accessible tissues, and even more so in the presence of atypical and monosymptomatic forms of MAS.
Asunto(s)
Análisis Mutacional de ADN/métodos , ADN/genética , Displasia Fibrosa Poliostótica/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Cromograninas , Humanos , Mosaicismo , Mutación/genética , Selección de Paciente , Sensibilidad y EspecificidadRESUMEN
One of the main features of McCune-Albright syndrome is bone fibrous dysplasia (BFD) often associated with severe clinical outcomes, such as bone pain, bone deformities and pathological fractures. Medical treatment with bisphosphonates started 15 years ago. Recent trials in pediatric patients with BFD have shown encouraging results. We evaluated long-term efficacy and safety of pamidronate treatment of BFD in children and adolescents with MAS. The drug was administered at 4 month-1 year intervals according to alkaline phosphatase levels. The study included 14 patients (10 females and 4 males between the ages of 5.3 and 18.7 years) with moderate or severe BFD. Follow up lasted 1.9-9 years. Bone pain, fractures, deformities, and bone turnover markers were evaluated before every therapeutic course. The study shows the beneficial effects of long-term bisphosponate treatment on BFD lesions leading to reduced fracture rate and bone pain, and radiological evidence of long bone lesion healing.
Asunto(s)
Conservadores de la Densidad Ósea/uso terapéutico , Difosfonatos/uso terapéutico , Displasia Fibrosa Poliostótica/tratamiento farmacológico , Fracturas Espontáneas/prevención & control , Adolescente , Fosfatasa Alcalina/metabolismo , Niño , Preescolar , Femenino , Displasia Fibrosa Poliostótica/complicaciones , Displasia Fibrosa Poliostótica/enzimología , Estudios de Seguimiento , Fracturas Espontáneas/tratamiento farmacológico , Fracturas Espontáneas/etiología , Humanos , Masculino , Dolor/tratamiento farmacológico , Dolor/prevención & control , Pamidronato , Estadísticas no Paramétricas , Resultado del TratamientoRESUMEN
Gonadal hyperfunction is the most frequent endocrine dysfunction in females with McCune-Albright syndrome (MAS). Peripheral precocious puberty is usually the first MAS manifestation in children, characterized by episodes of hypersecretion of estrogens with a consequent reduction in gonadotropin secretion. Little is known about the course of this endocrine disease in adolescence and during young adult life. The aim of this study was to evaluate ovarian function in 10 females with MAS (age 11.4-20.1 years) to detect the persistence of autonomous ovarian hyperfunction throughout and following adolescence, after at least 1 year wash out of any treatment for precocious puberty. LH, FSH, estradiol, prolactin, androgen secretion, ovarian and breast sonography in luteal and follicular phases of some menstrual cycles were evaluated. We demonstrated the persistence of some ovarian autonomy, documented by hyperestrogenism and/or low or absent gonadotropin secretion and/or ovarian cysts.
Asunto(s)
Estrógenos/metabolismo , Displasia Fibrosa Poliostótica/complicaciones , Quistes Ováricos/complicaciones , Ovario/fisiopatología , Pubertad Precoz/fisiopatología , Adolescente , Adulto , Determinación de la Edad por el Esqueleto , Niño , Preescolar , Femenino , Displasia Fibrosa Poliostótica/diagnóstico , Displasia Fibrosa Poliostótica/fisiopatología , Estudios de Seguimiento , Gonadotropinas/fisiología , Humanos , Ciclo Menstrual , Quistes Ováricos/diagnóstico por imagen , Quistes Ováricos/fisiopatología , Enfermedades del Ovario/etiología , Enfermedades del Ovario/metabolismo , Ovario/diagnóstico por imagen , Pubertad Precoz/complicaciones , Pubertad Precoz/diagnóstico , Pubertad Precoz/tratamiento farmacológico , Esteroides/uso terapéutico , Resultado del Tratamiento , UltrasonografíaRESUMEN
BACKGROUND: McCune-Albright syndrome (MAS) is characterized by the triad of polyostotic bone fibrous dysplasia (PFD), endocrine disorders, and café-au-lait skin pigmentation. Ninety percent of MAS patients have fibrous dysplasia (FD) craniofacial lesions. Osteonecrosis of the jaw (ONJ) has been described as an adverse side effect of bisphosphonate therapy. The aim of the study was to investigate evidence of clinical and/or radiological signs of ONJ in FD/MAS pediatric patients due to bisphosphonate therapy and describe odontoiatric tools in this population. METHODS: Thirteen FD/MAS patients were enrolled. All patients during pediatric age have been treated with pamidronate infusions. They underwent complete oral clinical examination. Ortopantomography and/or CT were evaluated in all cases. RESULTS AND CONCLUSIONS: No patient developed ONJ. None of them showed radiological signs different from jaw FD. In spite of the low number of patients enrolled, results confirm that, in this population, ONJ can be ruled out as a chronic adverse side effect of bisphosphonate therapy.
Asunto(s)
Difosfonatos/efectos adversos , Displasia Fibrosa Poliostótica/tratamiento farmacológico , Enfermedades Maxilomandibulares/inducido químicamente , Osteonecrosis/inducido químicamente , Enfermedades Dentales/inducido químicamente , Adolescente , Adulto , Niño , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Femenino , Estudios de Seguimiento , Humanos , Enfermedades Maxilomandibulares/patología , Masculino , Osteonecrosis/patología , Pronóstico , Enfermedades Dentales/patología , Adulto JovenRESUMEN
BACKGROUND: In male mice, targeted disruption of the homeobox gene hoxa10 causes cryptorchidism and infertility. Genetic alterations in exon 1 of HOXA10 have been found in a high number of boys with cryptorchidism. AIM: To evaluate whether mutations of HOXA10 can be a common cause of cryptorchidism. PATIENTS AND METHODS: Genomic DNA was extracted from 18 patients with cryptorchidism (age 7-44 years; unilateral n = 13; no familial cases) and 28 healthy controls (age 9-39 years). HOXA10 was amplified by PCR and all coding sequences of exon 1 and 2 were sequenced. The PCR products were digested by ScrFI restriction enzyme and the restriction fragments obtained were analyzed on 2% agarose gel. RESULTS: One silent polymorphism, G-->A substitution at position 1203, was detected in 2/18 patients (11.1%). The same polymorphism was detected in 3/28 controls (10.7%). CONCLUSIONS: These data on HOXA10 analysis indicate that alterations of this gene may be more rare in males with cryptorchidism than previously suggested. This finding agrees with the rare occurrence of INSL3 gene mutations in human cryptorchidism, but needs to be confirmed in a larger series of selected patients.
Asunto(s)
Criptorquidismo/genética , Proteínas de Unión al ADN/genética , Adolescente , Adulto , Niño , Criptorquidismo/fisiopatología , Análisis Mutacional de ADN , Proteínas Homeobox A10 , Proteínas de Homeodominio , Humanos , Masculino , Reacción en Cadena de la PolimerasaRESUMEN
McCune-Albright syndrome (MAS) is a rare disease caused by somatic postzygotic mutations at Arg201 in the GNAS1 gene that encodes for the Gsalpha protein. Arg201 mutations are gain-of-function mutations in affected tissues (including bone, skin, endocrine glands and other tissues) that result in the activation of cAMP. We used a polymerase chain reaction(PCR)-based technique for the selective enrichment and analysis of the Arg201 mutant allele in 27 different tissues from 24 Italian patients with one or more signs of MAS. Arg201 mutations were identified in 13 different tissues (48.1%) from 11 patients (45.8%). Mutation detection rates differed across the various types of tissue samples, and the mutation was not always found in every tissue sample from the same patient. To overcome problems in the analysis of mutations in somatic mosaicism, as occurs in MAS, a highly sensitive molecular technique should be applied, the most appropriate tissue source selected, and various affected tissues from the same patient analyzed.
Asunto(s)
Arginina/genética , Displasia Fibrosa Poliostótica/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Mutación/genética , Adolescente , Adulto , Alelos , Sustitución de Aminoácidos , Niño , Preescolar , Exones/genética , Femenino , Humanos , Italia , Masculino , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
A multicenter study on fibrous dysplasia of bone (FD) was promoted by the European Pediatric Orthopaedic Society in 1999 in order to gain insight into the natural history of the disease and to evaluate current diagnostic and therapeutic approaches. We collected and reviewed clinical, radiographic, pathological, and molecular genetic data when possible, from a total of 64 cases diagnosed as either monostotic FD (MFD), polyostotic FD (PFD), or McCune-Albright syndrome (MAS), evaluated or treated in 11 participating centers. Results from the initial analysis of the series indicate five main points: (1) Significant diagnostic pitfalls affect the diagnosis of MFD and, to a lesser extent, PFD in orthopedic centers and allied radiology and pathology facilities, which may be circumvented by the adoption of stringent diagnostic criteria, and in some cases by the analysis of FD-associated GNAS1 mutations. (2) MFD carries a significant risk for fracture in the face of limited disease in the proximal femur, whereas its tendency to progress is restricted to a minority of cases, and long-term outcome is usually satisfactory, regardless of treatment, in non-progressive cases. (3) The profile of tibial disease, both in MFD and in PFD, is markedly different from that of femoral disease. (4) As expected, MAS patients have the most extensive disease and the most complicated course, regularly experience multiple fractures, and require adequate surgical treatment. It appears that conservative treatment of femoral fracture, or curettage and cancellous bone grafting, or fixation with screws and plates are not indicated for the treatment of femoral fractures in these patients and should all be discouraged. Internal fixation with intramedullary nails provides stabilization of extensively affected bones, and prevents further fractures and major deformities, and thus providing a better option both for acute and elective surgery in patients with extensive involvement of the femur or of other limb long bones. (5) Evaluation of patients with FD at orthopedic centers should include, but rarely does, a thorough evaluation of endocrine profile and phosphate metabolism, and proper pathological and radiographic assessment.